Indeed, studies of breast cancer resistance suggest many other signaling pathways, for example, Pgr, androgen receptor, and GPER may be involved in the actions of tamoxifen on transcription (Mo et al., 2013; Rondón-Lagos et al., 2016). The gene discussed is AR; the disease is breast cancer.